Tumor-Directed Disulfidptosis via Spatiotemporally Controlled Copper Bioorthogonal Activation
ACS Nano · 10.03.2026 · 20 (9) · 7569-7588
DOI: 10.1021/acsnano.5c17848 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 24.02.2026. Verfasst von Yichen Yin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Anhui Provincial Key Laboratory of Precision Pharmaceutical Preparations and Clinical Pharmacy, The First Affiliated Hospital…. Hauptthemen laut MEDLINE: Copper, Disulfidptosis, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: University of Science and Technology of China, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Disulfidptosis, a recently discovered programmed cell death pathway, represents a promising therapeutic strategy for tumors, as its key modulator SLC7A11 is frequently overexpressed in tumor cells. However, inducing disulfidptosis selectively in tumor cells remains a challenge. In this study, we employed a copper-triggered bioorthogonal reaction to generate disulfidptosis agents, specifically in tumor cells. To achieve this goal, rhein-alkyne was encapsulated in ferritin, a tumor-targeting protein cage, in the form of a copper complex (Cu/rhein). With the cotreatment of a ruthenium complex azido-Ru-arene (Ru-N3), the Cu(I)-catalyzed azide-alkyne cycloaddition generates the cytotoxic product Ru-rhein in tumor cells. Ru-rhein induces disulfidptosis by downregulating glucose transporter 1 (GLUT1), which significantly decreases glucose and NADPH levels in tumor cells, resulting in aberrant accumulation of disulfide bonds and triggering of disulfidptosis. Meanwhile, the accumulation of copper ions from Cu/rhein promotes cuproptosis of tumor cells, further intensifying the disulfidptosis. The in vivo therapeutic effect of the bioorthogonal reactions has been confirmed in tumor-bearing mice. This work offers a therapeutic strategy by introducing copper-triggered bioorthogonal reactions to trigger disulfidptosis and cuproptosis, specifically, in tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Anhui Provincial Key Laboratory of Precision Pharmaceutical Preparations and Clinical Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Scienc…
- Key Laboratory of Precision and Intelligent Chemistry, School of Chemistry and Materials Science, University of Science and Technology of China, Hefei 230026, China.
- Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University, Nanjing 210023, China.
- School of Life Sciences, Anhui Agricultural University, Hefei 230036, China.
ORCID-Profile: Yichen Yin, Kaiming Cao, Yangzhong Liu
Förderung
- University of Science and Technology of China
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Plans for Major Provincial Science and Technology Projects
Zitieren
APA
Yin, Y., Yu, W., Shen, Z., Yuan, S., Cao, K., Liu, H. K., & Liu, Y. (2026). Tumor-Directed Disulfidptosis via Spatiotemporally Controlled Copper Bioorthogonal Activation. ACS Nano, 20(9), 7569-7588. https://doi.org/10.1021/acsnano.5c17848
Vancouver
Yin Y, Yu W, Shen Z, Yuan S, Cao K, Liu HK, et al. Tumor-Directed Disulfidptosis via Spatiotemporally Controlled Copper Bioorthogonal Activation. ACS Nano. 2026;20(9):7569-7588. doi:10.1021/acsnano.5c17848
BibTeX
@article{Yin2026,
author = {Yin, Yichen and Yu, Wenxin and Shen, Zhengqi and Yuan, Siming and Cao, Kaiming and Liu, Hong-Ke and Liu, Yangzhong},
title = {Tumor-Directed Disulfidptosis via Spatiotemporally Controlled Copper Bioorthogonal Activation},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {9},
pages = {7569--7588},
doi = {10.1021/acsnano.5c17848}
}
EUVIMED